# Comparative Effectiveness of Gadopiclenol for Evaluation of Adult Congenital Heart Anatomy and Hemodynamics

Study · id `cardio:ct-nct06406517` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06406517](<https://clinicaltrials.gov/study/NCT06406517>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT06406517

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 161 participants.

## Technical summary

Registry record NCT06406517. Randomized; triple masking; primary purpose other. Start 2024-08-05 (actual); primary completion 2026-04-23 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose other
- Phase: Phase 3
- Enrolled: 161 participants (enrolled count; ClinicalTrials.gov record NCT06406517, source copy `cardio:ctgov-nct06406517-2026-11-03`, retrieved 2026-11-18)
- Started: 2024-08-05 (actual) (ClinicalTrials.gov record NCT06406517, source copy `cardio:ctgov-nct06406517-2026-11-03`, retrieved 2026-11-18)
- Primary completion: 2026-04-23 (actual) (ClinicalTrials.gov record NCT06406517, source copy `cardio:ctgov-nct06406517-2026-11-03`, retrieved 2026-11-18)
- Completion: 2026-08-23 (actual) (ClinicalTrials.gov record NCT06406517, source copy `cardio:ctgov-nct06406517-2026-11-03`, retrieved 2026-11-18)
- Countries: United States (ClinicalTrials.gov record NCT06406517, source copy `cardio:ctgov-nct06406517-2026-11-03`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06406517-2026-11-03`, retrieved 2026-11-18)

## The registry's words

- Brief title: Comparative Effectiveness of Gadopiclenol for Evaluation of Adult Congenital Heart Anatomy and Hemodynamics
- Condition: Congenital Heart Disease
- Intervention (Drug): Gadopiclenol
- Intervention (Drug): Gadobenate dimeglumine
- Lead sponsor: University of California, San Diego
- Lead sponsor class: OTHER
- Collaborator: Bracco Imaging S.p.A.
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Adult congenital heart disease (`cardio:adult-congenital-heart-disease`)
- Registry condition terms include this condition: Congenital heart disease (`core:congenital-heart-disease`)
- Registry lists this organization as the lead sponsor: University of California, San Diego (`cardio:org-university-of-california-san-diego`)

## Provenance

Content hash: cbe39713c8464b7b285692c97e03212caf2355302dc2fae22c8fa16d41cbf5a5
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
